182. Aversa A., Isidori A.M., Spera G. et al. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction // Clin. Endocrinol. 2003. Vol 58. №5. P. 632-638.
183. Baltaci S., Aydos K., Kosar A., Anafarta K. Treating erectile dysfunction with a vacuum tumescence device: a retrospective analysis of acceptance and satisfaction // Br. J. Urol. 1995. Vol. 76. P. 757-760.
184. Barrett-Connor E. Cardiovascular risk stratification and cardiovascular risk factors associated with erectile dysfunction: assessing cardiovascular risk in men with erectile dysfunctio // Clin. Cardiol. 2004. Vol. 27. №1. P. 18-113.
185. Batstone G.R., Doble A., Gaston G.S. Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS) // Clin.Exp.Immunol. 2002. Vol. 128. P. 302-307.
186. Benet A.E., Melman A. The epidemiology of erectil dysfunction // Urol. Clinic of North America. 1995.V. 22. P. 699-709.
187. Bocchio M., Desideri G., Scarpelli P. Et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage // J.Urol. 2004. Vol. 171. P. 1601-1604.
188. Bratton R.L., Cassidy H.D. Vacuum erection device use in elderly men: a possible severecomplication // J.Am.Board Fam.Pract. 2002. N6. P.501-502.
189. Brohler E., Wurz J., Unger U. et al. The Gissen Prostatitis Symptom Score. Standardisation of the questionnaire andrevalence of symptoms // J. Urol. 1997. Vol. 157. 239 p.
190. Brunner H., Cockcroft J.R., Deanfield J et al. Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension // J.Hypertens. 2005. Vol. 23. P.233-246.
191. Burnett A.L. Role of nitric oxide in the physiology of erection // Biol.Reprod. 1995. Vol.52. P.485-489.
192. Cartledge J.J., Minhas S., Eardley I. et al. Endothelial and neuronal-derived nitric oxide mediated relaxation of corpus caver-nosal smooth muscle in a rat, in vitro, model of erectile function // Int. J. Import Res. 2000. Vol. 12. P. 213-221.
193. Cavallini G., Caracciolo S., Vitali G. Et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging // Urology. 2004. Vol. 63. P. 641-646.
194. Chen J., Mabjeesh N.J., Greenstein A. Sildenafil versus the vacuum erection device: patient preference // J. Urol. 2001. Vol. 166. P. 1779-1781.
195. Chen J., Sofer M., Kaver I. et al. Concomitant use of sildenafil and a vacuum entrapment device for the treatment of erectile dysfunction // J. Urol. 2004. Vol. 171. p. 292-295.
196. Chen R.Y., Wittert G.A., Andrew G.R. Relative androgen deficiency in relation to obsity and metabolic in older men // Diabetes. Obes. Metab. 2006. №4. P. 429-435.
197. Chevret M., Jaudinot E., Sullivan K. et al. Impact of erectile dysfunction (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) questionnaire // J. Sex. Marital. Ther. 2004.Vol. 30. P. 157-172.
198. Colins M.M., McDonald R. Diagnosis and treatment of chronic abacterial prostatitis // Ann.Intern.Med. 2000. V.133. P.40-43.
199. Contreras F., Rivera M., Vasques J. et al. Endothelial dysfunction in arterial hypertension // J. Hum.Hypertens. 2000. V.14. Suppl.11. P.20-25.
200. Corona G., Mannicci E., Mansani R. et al. Aging and pathogenesis of erectile dysfunction // Int. J. Import. Res. 2004. Vol.16. P. 395-402.
201. Corona G., PetroneL., Mannucci E. et al. Psycho-Biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions // Eur.Urol. 2004. Vol.46. P.615-622.
202. Coyne K.S., Sexton C.C., Irwin D.E. et al. The impact of overactive bladder, incontinence and other lower urinery tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: result from the EPJC study // Br.J.Urol.Int. 2008. N11. P.1388-1395.
203. Dalkin B.L., Christopher B.A. Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device // Int.J.Import.Res. 2007. N5. P.501-504.
204. Denil J., Ohl D.A., Smythe C. Vacuum erection device in spinal cord injured men: patient and partner satisfaction // Arch. Phys. Med. Rehabil. 1996. Vol. 77. P. 750-753.
205. Eardley F. Imaging for erectile dysfunction // Current Opinion in Urology. 2002. Vol. 17. P. 143-147.
206. El Sakka A.J., Morsy A.M., Fagih B.J., Nassar A.H. Coronary artery risk factors in patients with erectile dysfunction // J. Urol. 2004. Vol.172. P.251-254.
207. Elert A., Von Knobloch R., Nusser R. et al. Isolated candidal prostatitis // J. Urol. 2000. Vol. 163. 244 p.
208. Fall M., Baranowski A.P., Fowler C.J. et al. EAU guidelines on chronic pelvic pain // Eur. Urol. 2004. Vol. 46. P. 681-689.
209. Fernandez Arjona M., Oteros R., Zarca M. et al. Percutaneos embolization for erectile dysfunction due to venous leakage: prognostic factors for a good therapeutic result // Eur. Urol. 2001. Vol. 39. P. 15-19.
210. Ferrini M.G., Davila H.H., Valente E.G. et al. Aging-related induction of inducible nitric oxide synthase is vasculoprotective to the arterial media // Cardiovasc.Res. 2004. Vol.61. P.796-805.
211. Fisher W. A., Rosen R. C., Eardley I. et al. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study // J. Sex. Med. 2005. № 2. P. 675--684.
212. Foresta C., Carreta N., Rossato M. et al. Role of androgens in erectile function // J. Urol. 2004. Vol.171. P.2358-2362.
213. Fung M.M., Bettencourt R., Barrett-Connor E. Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo study // J. Am. Coll.Cardiol. 2004. P.1405-1411
214. Ganem J.P., Lucey D.T., Janosko E.O., Carson C.C. Unusual complications of the vacuum erection device // Urology. 1998. Vol. 51. P. 627-631.
215. Getz G.S. Fematic review series: Immune function in atherogenesis // J.Lipid.res. 2005. V.46. P.1-10.
216. Giuliano F., Rampin O. Central control of erection and its pharmacological modification // Curr. Opin. Urol. 2000. Vol. 10. P. 629-633.
217. Hayes F.J., de Cruz S., Seminara S.B. et al. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion // J. Clin. Endocrinol. Metab. 2001. Vol. 86. P. 53-58.
218. Hayes F.J., Pitteloud N., de Cruz S. et al. Importance of inhibin B in the regulation of FSH secretion in the human male // J. Clin. Endocrinol. Metab. 2001. Vol. 86. P. 5541-5546.
219. Hatzichristou D.G., Pescatori E.S. Current treatments and emerging therapeutic approaches in male erectile dysfunction // B.J.U.Int. 2001. Vol. 88.№ 3. P. 11-17.
220. Heaton J., Haken G.J., Savage D., Radley R.J. Patient choice is critical in managing erectile dysfunction // Eur.Urol. 2002. N1. P.33-37.
221. Hernandez-Pando R., Orozcoe H., Sampieri A. et al. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis // Immunology. 1996. Vol.89. P.26-33.
222. Hochreiter W.W., Duncan J.L., Schaeffer A.J. Evaluation of the bacterial flora of the prostate using a 16SrRNA gene based polymerase chain reaction // J.Urol. 2000. Vol. 163. P. 127-130.
223. Hochreiter W., Nadler R., Koch A. et al. Evaluation of interleikin-8 (IL-8)
as indicator of inflammation in prostatic secretion// In: XV-th Congr. Eur. Association of Urology, April, 12-15, 2000, Brussels //Eur. Urol.2000.Vol.37.P. 45.
224. Hurt K. J., Musicki В., Palese M. A. et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection // Proc. Natl. Acad. Sci. USA. 2002. Vol. 99. P. 4061-4068.
225. Ignarro L.J., Napoli C., Loscalzo J. Nitric Oxide Donors and cardiovascular Agents Modulating the Bioactivity of Nitric Oxide: An Overview // Circ.Res. 2002. Vol.90. P.21-28.
226. Jankowski J.T., Sefter A.D., Strohl K.P. Erectile dysfunction and sleep related disorders // J. Urol. 2008. №3. P. 837-841.
227. Kirby R.S. An Atlas of Prostatic Diseases. The Encyclopedia of Visial Medicine Series. The Parthenon Pablishing Group. New-Jerk-London, 1997. 96 p.
228. Kirby M. A new look at the hormonal and metabolic changes in the ageing male // Int. J. Clin. Pract. 2008. №5. P. 672-674.
229. Krieger J.N., Takahashi S., Riley D.E. Chronic prostatitis: role of uncommon organisms // Eur. Urol. Suppl. 2003. Vol. 2. P. 19-22.
230. Lazamo G., Pagliaro P., Gatullo D., Marsh N.A. Control of coronary blood flow by endothelial release of nitric oxide // Clin/Exp.Pharmacol.Physiol. 1994. V.21. P.783-789.
231. Lee D., Sikka S.C. Standardization of penile blood flow parameters in normalmen using intracavernosus prostaglandin E1 and visual sexual stimulation // J. Urology. 1993. Vol. 149. P. 49-52.
232. Levine L.A., Dimitriou R.J. Vacuum constriction and external erection devices in erectile dysfunction // Urol.Clin.N.Am. 2001. N2. P.335-341.
233. Levine L.A., Estrada C.R., Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: resuits of a 2 center study // J. Urol. 2001. Vol. 166. P. 932-937.
234. Lummus W.E., Thompson J. Prostatitis // Emerg.Med.Clin.North.Am. 2001. Vol.19. P.691-707.
235. Maas R., Schwedhelm E., Albsmeier J., Boger H.R. The pathophysiology of erectile dysfunction melated to endothelial dysfunction and mediators of vascular function // Vasc. Med.2002.Vol.7.P.213-225.
236. McMahon C.G., Abdo C., Hull E. et al. Disorders of orgasm and ejaculation in men. Sexual medicine: sexual dysfunctions in men and women. Paris: Chap. 2004. 13 p.
237. McNaughton-Collins M., Fowler F.J., Ellitt D.B. et al. Diagnosing and treating prostatitis: do urologists do the four glass test? // Urology. 2000. Vol. 55. P. 403-407.
238. McNaughton-Collins M., O`Leary M.P., Litwin M.S. et al. Quality of life is impaired in men with chronic prostatitis: results from the NIH cohort study // J. Urol. 2000. Vol. 163. P. 23-47.
239. Mehik A., Hellstrom P., Lukkarinen O. et al. Epidemiology of prostatitis in Finnish men: a population-based cross-secretion study // Br. J. Urol. 2000. Vol.86. P. 443-448.
240. Mehik A., Hellstrom P., Sarpola A. et al. Fears, sexual disturbances and personality features in men with prostatitis: a population-based crosssectional study in Finland // BJU Int. 2001. Vol. 88. №1. P. 35-38.
241. Miller S. A., Byers E. S. Actual and desired duration of foreplay and intercourse: discordance and misperceptions within heterosexual couples // J. Sex. Res. 2004. Vol. 41. P. 301--309.
242. Montague D.K., Jarow J., Broderick G.A. et al. AUA guideline on the pharmacologic management of premature ejaculation // J.Urol. 2004. Vol.172.P.290-294.
243. Morales A., Heaton J.P.W. Hormonal erectile dysfunction: evaluation and management // Urol. Clin. 2001 - №28. p. 279-287.
244. Morales A., Buvat J., Gooren L.J. et al. Endocrine aspects of men sexual dysfunction // Sexual medicine. Sexual dysfunctions in men and women. 2006. №11. P. 347-382.
245. Morant S., Bloomfield G., Vats V., Chapple C. Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms // J.Sex.Med. 2009. N4. S.1103-1110.
246. Moreland R.B., Albadawi H., Bratton Ch.et al. O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle // AJP-Heart. 2001. Vol.282. P.552-558.
247. Mulhall J.P., Abdel-Moneim A., Abobacr R., Goldsteyn I. Impruving the accuracy of vascular testing impotent men correcting hemodynamic alteration using a vasoactive re-dosingschedule // J.Urol. 2001. Vol. 166. P. 923-926.
248. Nadler R.B., Koch A.E., Calhoun E.A. et al. IL-1 beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis // J.Urol. 2000. Vol. 164. P. 214-218.
249. Nickel J.C. Chronic prostatitis: an infectious disease? // Infect. Urol. 2000. Vol. 13. P. 31-38.
250. Nickel J.C., Downey J., Hundter D., Clark J. Prevalence of prostatitis-like symptoms in a population-based study using the National Institutes of Health Chronic Prostatitis Symptom Index // J.Urol. (Baltimore). 2001. Vol.165. P.842-845.
251. Nickel J.C. The Prostatitis Manual // Bladon Medical Publishing. 2002. P.55-80.
252. Nickel J.C. Recommendations for the evaluation of patients with prostatitis //World J.Urol. 2003. Vol. 21. P. 75-81.
253. Nickel J.C. Clinical Evaluation of the Patient Presenting with Prostatitis // Eur. Urol. Suppl. 2003. №2. P. 11-17.
254. Nickel J.C. Chronic pelvic pain syndrome. The biomedocal model has failed! So, what's next? // Contemp.Urol. 2006. N6. P.31-39.
255. Nickel J.C., Roehrborn C.G., O'Leary M.P. et al. Examination of the relationship between symptoms of prostatitis and histological imflammation: baseline data from the reduce chemoprevention trial // J.Urol.(Baltimor). 2007. N3. P.896-900.
256. O'Leary M.P., Litwin M.S. et al. Quality of life is impaired in men with chronic prostatitis: results from the NJH cohort study // J.Urol. 2000. Vol.163. P.23-34.
257. Pan L.J., Xia X.Y. Androgen deficiency and erectile dysfunction // Clin. endocrinology. 2006. №11. P. 1030-1034.
258. Pankaj Jain, Alfred W. Rademaker, Kevin T.Mcvary. Testosterone Supplementation for erectile disfunction: result of meta-analysis // J. Urology. 2000. August. 2. P. 371-375.
259. Paraddoukakais S., Alamanis C. Correlation of Risk Factors for Erectile Disfunction and Vascular Disorders in Penile Vasculature // 5th Congress of the Europen Society for Sexual and Impotence Research. Hamburg. Germany, 2002. P. 3-17.
260. Pescatori E.S., Silingardi V., Galeazzi G.M. Audiovisual sexual stimulation by virtual glases in effective in inducing complete cavernosal smooth muscle relaxation: a pharmacocavernosometric stady // Int. J. Impotence Res. 2000. Vol. 12. P. 83-90.
261. Potty J.M. Alternative approaches to the management of prostatitis: biofeedback, progressive relaxation, the concept of somatic syndromes // Eur. Urol. Suppl. 2003. Vol. 2. P.34-37.
262. Potts J.M. Prospective identification of national institutes of Health Category IV prostatitis in men with elevated prostate specific antigen // J. Urol. 2000. Vol. 164. P. 1550-1553.
263. Raghu G., Brown K.K., Bradford W.Z. et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis // N.Engl.J.Med. 2004. Vol.350. P.125-133.
264. Richard G., Batstone D., Doble A. Chronic prostatitis // Curr. Opin. Urol. 2003. №13. P. 23-29.
265. Roberts R.O., Lieber M.M., Bostwick D.G. et al. A review of clinical and pathological prostatitis syndromes // Urology. 1997. Vol. 49. P. 809-821.
266. Rosen R.C., Filey F., Wagner G.et al. The international index of erectile function (JJEF): a multidimensional seale for asistment of erectile dysfunction // Urology. 1997. V.49. P.822-829.
267. Rosen R.C. Psychogenic erectile dysfunction // Urol.Clin.North.Am. 2001. Vol.28. P.269-278.
268. Rosen R., Altwein J., Boyle P.et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7) // Progr. Urol. 2004. N3. P.332-344.
269. Rosen R. C., Fisher W. A., Beneke M. et al. The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment // Br. J. Urol. Int. 2007. Vol. 99. P. 849-859.
270. Saenz de Tejada I., Angulo J., CelleK S. Et al. Physiology of erectile function and pathophysiology of erectile dysfunction. Sexual medicine: sexual dysfunctions in men and women. Paris: Chap., 2004. 10 p.
271. Sakamoto H. Hemodynamic evaluation of the penile arterial system in patients with erectile dysfunction using power Doppler imaging // Urology. 2002- V. 60. № 3. P. 480-484.
272. Seftel A.D., Monammed M.A., Althof S.E. Erectile dysfunction: etiology, avaluation and treatment options // Med.Clin.North.Am. 2004. Vol.88. P.387-416.
273. Shaeffer A.J., Stern J. Chronic prostatitis // Clin. Evid. 2002. Vol. 70. P. 788-795.
274. Schaeffer A.J. Epidemiology and demographics of prostatitis // Eur. Urol. 2003. Vol. 2. P. 5-10.
275. Screponi E., Carosa E., Di Stasi S.M. et al. Prevalene of chronic prostatitis in men with premature ejaculation // Urology. 2001. Vol.58. P.198-202.
276. Shah J. Erectyle dysfunction through the ages // B. J. U. 2002.V. 90.P. 433- 441.
277. Shahed A., Shoskes D.A. Oxidative stress in prostatic fluid of men with chronic pelvic pain syndrome: correlation with bacterial growth and treatment response // J. Urol. 2000. Vol. 163. 24 p.
278. Shamloul R. Peak systolic velocities may be falsely in young patients with erectile dysfunction // J. Sex. Med. 2006. №3. P. 138-143.
279. Shoskes D.A., Shahed A. Presence of bacterial signal in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pain syndrome // J. Urol. 2000. Vol. 163. 23 p.
280. Shoskes D.A., Lel C.T., Myrphy D. et al. Incidence and significance of prostatic stones in men with chronic prostatitis/chronic pelvic pain syndrome // Urology. 2007. P.235-238.
281. Solomon H., Man J. W., Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common et denominator // Heart. 2003. Vol. 89. P. 251--254.
282. Svihra J., Elias B., Javorka K.J., Kliment J. Diagnosis and treatment of functional disorders of the lower urinary tract in younger men // Bratist.Lek.Listy. 2000. N5. P.302-305.
283. Traish A.M., Munarriz R., O'Connell L. et al. Effects of medical or surgical on erectile function in an animal model // J. Androl. 2003. Vol. 24. P. 381-387.
284. Traish A.M., Guay A.T. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence // J. Sex. Med. 2006. №3. P. 382-404.
285. Vignozzi L., Corona G., Petrone L. et al. Testosterone and sexual activity // Endocrinol. Invest. 2005. Vol.28. P. 39-44.
286. Virag R. Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content // J. Mai. Vase. 2002. Vol. 27. №4. P. 214-217.
287. Virag R., Floresco J., Richard C. Impairment of shear stress-mediated vasodilatation of cavernous arteries in erectile dysfunction // Int.J. Import.Res. 2004. Vol.16. P. 39-42.
288. Vlachopoulos C., Aznaouridis K., Joakeimidis N.et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease // Eur.Heart.J. 2006. Vol.27.№22. P.2640-2648.
289. Wagner G., Mulhall J. Pathophysiology and diagnosis of male erectile dysfunction // Br. J. Urol. 2001. V. 88. Suppl. 3. P. 3-10.
290. Wagner G., Fugl-Meyer K. S., Fugl-Meyer A. R. Impact of erectile dysfunction on quality of life: patient and partner perspectives // Int. J. Impot. Res. 2000; 12 (Suppl. 4): S. 144-S146.
291. Waldinger M.D., Quinn P., Dilleen M. et al. A multinational population survey of Intravaginal Ejaculation Latency Time // J. Sex Medicine. 2005. Vol. 2. P. 492-497.
292. Waldinger M.D., Zwinderman A.H., Olivier B., Schweitzer D.H. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data // J. Sex Medicine. 2005. Vol. 2. P. 498-507.
293. Wein A.J., Coyne K.S., Tubaro A.et al. The impact of lower urinary tract symptoms on male sexual health: EpiLUTS // Br.J.Urol.Int. 2009. N3. P.33-41.
294. Weiss P., Brody S. Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay // J. Sex. Med. 2009. № 6. P. 135-141.
295. Wenninger K., Heiman J.R., Rothman I. et al. Sickness impact of chronic nonbacterial prostatitis and its correlates // J. Urol. 1996. Vol. 155. P. 956-968.
296. Weskott H.P. B-flow a new method for detecting blood flow // Ultraschall Med. 2000. Vol. 21. №2. P. 59-65.
297. Wespes E. Smooth Muscle pathology and erectile dysfunction // Int. J. Impotence Res. 2002. Vol. 14. P. 17-20.
298. Wespes E., Amar E., Hatzichristou D. et al. Guidelines of Erectile Dysfunction // European Urology. 2007. Vol. 41. P. 1-5.
299. Whyte M., Hubbard R., Meliconi R. et al. Increased risk of fibrosing alveolitis assiciated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms // Am.J.Respir.Crit.Care Med. 2000. Vol.162. P.755-758.
300. Wynes M.W., Frankel S.K., Riches D.W.H. JL-4-induced macrophage-derived JGF-1 protects myofibroblasts from apoptosis induced by growht factor withdrawal // J.Leukoc. Biol. 2004. Vol.76. P.10-19.
301. Yassin A.A., Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only // J. Sex. Med. 2007. №2. P. 497-501.